(Press-News.org) Retinal damage is one of the most common complications of diabetes, affecting about 90 percent of type 1 diabetics and 75 percent of type 2 diabetics. According to the World Health Organization (WHO), diabetic retinopathy is the leading cause of blindness in adults of working age, and its incidence is showing an upward trend.
The retina is the part of the eye that converts optical images into nerve signals, which are then transmitted to the brain where vision is interpreted. Numerous proteins and molecules are involved in the process of signal transduction. Diabetic retinal damage leads to impaired function of these proteins. Within the framework of research projects of the German Center for Diabetes Research (DZD), scientists of the Research Unit Protein Science (PROT) and the Institute of Experimental Genetics (IEG) at Helmholtz Zentrum München (HMGU) have now investigated how drug treatment affects these signal carriers. They compared the concentrations of proteins in the retinas of non-diabetic mice, of mice with type 2 diabetes without treatment and of type 2 diabetic mice that were treated with the standard drug metformin, which lowers blood glucose levels and thus reduces diabetes complications. A total of 98 proteins were differentially abundant in the diabetic animals. About half of the proteins were normalized by treatment with metformin. The other proteins were unchanged, however, despite treatment and improved blood glucose levels. Among these was the protein VGLUT1, which is essential for signal transduction in specific nerve cells.
"Our results show that normalized blood glucose levels alone are not sufficient to fully treat diabetic retinopathy," said Dr. Alice Ly (PROT), lead author of the study. "In further studies we want to examine how different combination therapies affect the retinal proteins, in order to achieve a better understanding of the causes and treatment of this diabetes complication," added Dr. Stefanie Hauck (PROT).
The most common diseases in the population, such as type 2 diabetes, are the focus of research at Helmholtz Zentrum München. The aim is to develop new approaches to diagnosis, treatment and prevention.
###
Further Information
Original publication:
Ly, A. et al. (2013), Retinal proteome alterations in a mouse model of type 2 diabetes, Diabetologia, doi: 10.1007/s00125-013-3070-2
Link to publication: http://link.springer.com/article/10.1007/s00125-013-3070-2/fulltext.html
As German Research Center for Environmental Health, Helmholtz Zentrum München pursues the goal of developing personalized medical approaches for the prevention and therapy of major common diseases such as diabetes mellitus and lung diseases. To achieve this, it investigates the interaction of genetics, environmental factors and lifestyle. The Helmholtz Zentrum München has about 2,100 staff members and is headquartered in Neuherberg in the north of Munich. Helmholtz Zentrum München is a member of the Helmholtz Association, a community of 18 scientific-technical and medical-biological research centers with a total of about 34,000 staff members. http://www.helmholtz-muenchen.de
The German Center for Diabetes Research (DZD) brings together experts in the field of diabetes research and interlinks basic research, epidemiology and clinical applications. Members are the German Diabetes Center in Düsseldorf, the German Institute of Human Nutrition (DIfE) in Potsdam-Rehbrücke, Helmholtz Zentrum München – German Research Center for Environmental Health, the Paul Langerhans Institutes of the University Hospital Carl Gustav Carus in Dresden and the University of Tübingen, as well as the Gottfried Wilhelm Leibniz Association and the Helmholtz Association of German Research Centres. The objective of the DZD is to find answers to open questions in diabetes research by means of a novel, integrative research approach and to make a significant contribution to improving the prevention, diagnosis and treatment of diabetes mellitus. http://www.dzd-ev.de
The independent Research Unit Protein Science (PROT) investigates the composition of protein complexes and their integration into cellular processes and protein networks. One focus is the analysis of the interaction of genetic variance and environmental factors in neurodegenerative and metabolic diseases. The aim of this research is to identify biological systems and disease-associated disorders on a systemic level, thus contributing to a molecular understanding of diseases.
The research objective of the Institute of Experimental Genetics (IEG) is to elucidate the causes and pathogenesis of human diseases. Due to its prominent role in interdisciplinary and international consortia, the IEG is a global leader in the systemic study of mouse models for human diseases and the elucidation of involved genes. The main focus is on metabolic diseases such as diabetes. The IEG is part of the Helmholtz Diabetes Center (HDC).
Scientific Contact
Dr. Stefanie Hauck
Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH)
Research Unit Protein Science
Ingolstädter Landstr. 1, 85764 Neuherberg
Tel.: 089-3187-3941
E-Mail: hauck@helmholtz-muenchen.de
Prof. Dr. Marius Ueffing
Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH)
Research Unit Protein Science
Ingolstädter Landstr. 1, 85764 Neuherberg
Tel.: 089-3187-3567
E-Mail: marius.ueffing@helmholtz-muenchen.de
Study explains why diabetic retinopathy is difficult to treat
2013-10-07
ELSE PRESS RELEASES FROM THIS DATE:
Smoking affects molecular mechanisms and thus children's immune systems
2013-10-07
This news release is available in German.
Leipzig/ Halle. The Leipzig Helmholtz Center for Environmental Research has gained new insights on the influence of tobacco smoke in utero. For the first time, it could be demonstrated with smoking pregnant women and their children, how exposure to tobacco smoke affects the development of human immune system on molecular level. The focus thereby was on microRNA – a short, single-stranded RNA molecule that is now recognised as playing an important role in gene regulation.
For some time now, the impact of environmental ...
UltraHaptics -- it's magic in the air
2013-10-07
A system that allows users to experience multi-point haptic feedback above an interactive surface without having to touch or hold any device will be unveiled this week [Friday 11 October] at one of the world's most important conferences for innovations in human-computer interfaces.
Multi-touch surfaces offer easy interaction in public spaces, with people being able to walk-up and use them. However, people cannot feel what they have touched. A team from the University of Bristol's Interaction and Graphics (BIG) research group have developed a solution that not only allows ...
Stress steroid mediated withdrawal anxiety in dependent rats reversible by flumazenil
2013-10-07
Brooklyn, NY (October 7, 2013) – SUNY Downstate Medical Center announced today that Sheryl Smith, PhD, professor of physiology and pharmacology, has published new findings demonstrating a reproducible pathology that may help shed light on anxiety and mood volatility in methamphetamine dependence. In her animal study, Dr. Smith demonstrates that neuroactive stress steroids can trigger identifiable changes to the brains of methamphetamine dependent rats in withdrawal. Interestingly, Dr. Smith notes, these changes appear to be reversible by an existing pharmacological agent ...
Carnegie Mellon motion tracking technology is extremely precise, inexpensive with minimal lag
2013-10-07
PITTSBURGH—Researchers at Carnegie Mellon University and Disney Research Pittsburgh have devised a motion tracking technology that could eliminate much of the annoying lag that occurs in existing video game systems that use motion tracking, while also being extremely precise and highly affordable.
Called Lumitrack, the technology has two components — projectors and sensors. A structured pattern, which looks something like a very large barcode, is projected over the area to be tracked. Sensor units, either near the projector or on the person or object being tracked, can ...
Study identifies essential molecule in formation of differentiated blood cells
2013-10-07
CINCINNATI – New research in the Journal of Experimental Medicine identifies a protein that controls the formation of different types of mature blood cells – a finding that could be important to developing new treatments for blood diseases and helping realize the potential of regenerative medicine.
Researchers from Cincinnati Children's Hospital Medical Center report their results in a study published online by the journal Oct. 7. The authors focus on a protein called RhoA, a GTPase that serves as a molecular switch in the cytoplasm of cells to control cell function. ...
Vaccination campaign doubles HBV mutations
2013-10-07
WASHINGTON, DC – October 7, 2013 – A universal infant vaccination campaign in China has led the Hepatitis B virus (HBV) to more than double its rate of "breakout" mutations. These mutations may enable the virus to elude the vaccine, necessitating new vaccination strategies. Researchers at the Chinese Centers for Disease Control and Prevention and University of North Carolina, Chapel Hill, report their findings in an article published ahead of print in the Journal of Virology.
Until a universal vaccination program for infants was implemented in 1992, nearly ten percent ...
'White graphene' halts rust in high temps
2013-10-07
HOUSTON – (Oct. 7, 2013) – Atomically thin sheets of hexagonal boron nitride (h-BN) have the handy benefit of protecting what's underneath from oxidizing even at very high temperatures, Rice University researchers have discovered.
One or several layers of the material sometimes called "white graphene" keep materials from oxidizing – or rusting -- up to 1,100 degrees Celsius (2,012 degrees Fahrenheit), and can be made large enough for industrial applications, they said.
The Rice study led by materials scientists Pulickel Ajayan and Jun Lou appears today in the online ...
What makes triathletes so tough?
2013-10-07
Triathletes participate in a grueling endurance sport, swimming, bicycling, and running long distances without rest. In training and competitions, they regularly push their bodies beyond the limits most of us can endure. But while there is no doubt that triathletes are tough, very little is known about what gives them their exceptional abilities.
Now researchers at Tel Aviv University have discovered a possible explanation. Prof. Ruth Defrin and her doctoral student Nirit Geva of the Department of Physical Therapy at TAU's Sackler Faculty of Medicine have found that triathletes ...
For liberals and conservatives, 'belief superiority' is bipartisan
2013-10-07
DURHAM, N.C. -- As the budget crisis drags on, at least conservatives and liberals have something in common: both believe their views on certain issues are not only correct but all other views are inferior.
A study from Duke University examined whether one end of the American political spectrum believes more strongly than the other in the superiority of its principles and positions. It found both sides have elements of "belief superiority," depending on the issue.
When asked about nine hot-button issues, conservatives feel most superior about their views on voter identification ...
Boston University researchers test effectiveness of treatments for alcoholism and anxiety
2013-10-07
Domenic Ciraulo, MD, chair of psychiatry at Boston University School of Medicine (BUSM) and David H. Barlow, PhD, professor of psychology at Boston University (BU), have collaborated to study the effect of behavioral and medication treatments on patients with alcoholism and anxiety.
The findings, published in the journal Behaviour Research and Therapy, suggest that Transdiagnostic cognitive behavioral therapy (CBT) was more effective in reducing heavy drinking in anxious alcoholics than progressive muscle relaxation therapy (PMR). They also found that the addition of ...